Funded Startups in Heverlee
Recent disclosed funding in Heverlee is dominated by a single outlier: Coultreon Biopharma’s $125M Series A on 2026-04-28, which dwarfs the next-largest di…
Recent disclosed funding in Heverlee is dominated by a single outlier: Coultreon Biopharma’s $125M Series A on 2026-04-28, which dwarfs the next-largest disclosed amount in the list ($330K for Oxurion on 2024-03-04), with only one other entry above $5M (Pharrowtech at $5M on 2024-07-24). Sector-wise, biotechnology is concentrated: 2 of the 5 companies shown are biotech (Coultreon Biopharma and Oxurion), while the remaining entries split across Energy (Astracite), Consumer Electronics (Pharrowtech), and Transportation (IVEX).
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round among the most recent Heverlee entries, and how does it compare to the rest?
Coultreon Biopharma’s $125M (Series A) on 2026-04-28 is the only disclosed amount in the $100M range here; every other disclosed round is $5M or less, including Oxurion’s $330K on 2024-03-04 and Astracite’s $870K on 2026-06-16.
Do these entries cluster in time, or are they spread out across years?
They’re spread across more than three years: the oldest listed round is IVEX on 2023-02-23 (Seed, undisclosed), while the most recent is Astracite on 2026-06-16 (Pre-Seed, $870K). There’s also a tight biotech pair in 2024: Oxurion ($330K) on 2024-03-04 and Pharrowtech ($5M, Series Unknown) on 2024-07-24.
Are any sectors over-represented among the 5 companies shown?
Biotechnology appears in 2 of 5 entries (Coultreon Biopharma and Oxurion), which is the only repeated sector in this slice. The other sectors are singletons: Energy (Astracite), Consumer Electronics (Pharrowtech), and Transportation (IVEX).
How does the stage mix look across disclosed and undisclosed amounts?
Stages are uneven across the five rows: one Series A (Coultreon Biopharma, $125M on 2026-04-28), one Seed (IVEX on 2023-02-23, undisclosed), one Pre-Seed (Astracite, $870K on 2026-06-16), and one Series Unknown (Pharrowtech, $5M on 2024-07-24). Oxurion’s row lists an empty stage field alongside a disclosed $330K amount on 2024-03-04.
Are there outliers besides the largest round worth flagging?
Yes: the smallest disclosed amount is Astracite’s $870K (2026-06-16) versus Oxurion’s $330K (2024-03-04) and Pharrowtech’s $5M (2024-07-24), while IVEX is an outlier on disclosure because the amount is undisclosed even though it’s the only 2023 Seed entry. The main economic outlier remains Coultreon Biopharma’s $125M, which is far above all other disclosed figures in the list.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.